DexCom has long-term tailwinds given the continued growth of the global diabetes market, mainly due to growing levels of obesity. The emerging and already huge GLP-1 weight loss sector could ...
SAN FRANCISCO—After securing FDA clearance for its G7 continuous glucose monitor system last month, Dexcom is ready to begin adding the U.S. to its list of launch sites across the globe this quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback